Avantax Planning Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$408K Sell
3,676
-27
-0.7% -$2.99K 0.01% 298
2025
Q1
$415K Buy
3,703
+44
+1% +$4.93K 0.01% 287
2024
Q4
$338K Buy
3,659
+322
+10% +$29.7K 0.01% 313
2024
Q3
$280K Sell
3,337
-338
-9% -$28.3K 0.01% 346
2024
Q2
$252K Sell
3,675
-49
-1% -$3.36K 0.01% 393
2024
Q1
$273K Sell
3,724
-658
-15% -$48.2K 0.01% 377
2023
Q4
$355K Sell
4,382
-118
-3% -$9.56K 0.01% 274
2023
Q3
$337K Buy
4,500
+644
+17% +$48.3K 0.01% 268
2023
Q2
$297K Buy
3,856
+14
+0.4% +$1.08K 0.01% 296
2023
Q1
$319K Sell
3,842
-137
-3% -$11.4K 0.01% 280
2022
Q4
$342K Buy
3,979
+273
+7% +$23.4K 0.01% 281
2022
Q3
$229K Buy
+3,706
New +$229K 0.01% 307
2022
Q2
Sell
-3,395
Closed -$202K 355
2022
Q1
$202K Buy
3,395
+566
+20% +$33.7K 0.01% 342
2021
Q4
$205K Sell
2,829
-471
-14% -$34.1K 0.01% 335
2021
Q3
$231K Hold
3,300
0.01% 294
2021
Q2
$227K Sell
3,300
-621
-16% -$42.7K 0.01% 294
2021
Q1
$253K Sell
3,921
-834
-18% -$53.8K 0.01% 265
2020
Q4
$277K Sell
4,755
-1,103
-19% -$64.3K 0.01% 238
2020
Q3
$370K Buy
5,858
+915
+19% +$57.8K 0.02% 210
2020
Q2
$380K Buy
4,943
+512
+12% +$39.4K 0.02% 197
2020
Q1
$331K Sell
4,431
-4,971
-53% -$371K 0.02% 194
2019
Q4
$611K Sell
9,402
-702
-7% -$45.6K 0.04% 150
2019
Q3
$640K Buy
10,104
+339
+3% +$21.5K 0.04% 143
2019
Q2
$659K Buy
9,765
+493
+5% +$33.3K 0.04% 138
2019
Q1
$603K Buy
9,272
+1,982
+27% +$129K 0.04% 145
2018
Q4
$456K Buy
7,290
+36
+0.5% +$2.25K 0.03% 154
2018
Q3
$560K Sell
7,254
-1,496
-17% -$115K 0.04% 132
2018
Q2
$620K Sell
8,750
-85
-1% -$6.02K 0.06% 118
2018
Q1
$665K Sell
8,835
-156
-2% -$11.7K 0.06% 140
2017
Q4
$644K Sell
8,991
-1,967
-18% -$141K 0.06% 143
2017
Q3
$888K Sell
10,958
-10,091
-48% -$818K 0.07% 133
2017
Q2
$1.49M Buy
21,049
+1,493
+8% +$106K 0.13% 80
2017
Q1
$1.33M Sell
19,556
-173
-0.9% -$11.7K 0.12% 76
2016
Q4
$1.41M Buy
+19,729
New +$1.41M 0.15% 64